Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Irina Cleemput

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
Drug Discovery Today|September 30, 2018
Factors and situations influencing the value of patient preference studies along the medical product lifecycle: a literature reviewEline van Overbeeke, Chiara Whichello, Rosanne Janssens, et al.
Health Policy (Amsterdam, Netherlands)|August 26, 2020
An overview of critical decision-points in the medical product lifecycle: Where to include patient preference information in the decision-making process?Chiara Whichello, Karin Schölin Bywall, Jonathan Mauer, et al.
International Journal of Technology Assessment in Health Care|March 10, 2015
Developing the HTA core model for the online environmentKristian Lampe, Iris Pasternack, Oskari Saarekas, et al.
BMC Medical Informatics and Decision Making|October 6, 2019
Opportunities and challenges for the inclusion of patient preferences in the medical product life cycle: a systematic reviewRosanne Janssens, Isabelle Huys, Eline van Overbeeke, et al.
International Journal of Technology Assessment in Health Care|December 25, 2009
Testing the HTA core model: experiences from two pilot projectsIris Pasternack, Heidi Anttila, Marjukka Mäkelä, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|August 18, 2021
Belgian population norms for the EQ-5D-5L, 2018Lisa Van Wilder, Rana Charafeddine, Philippe Beutels, et al.
Frontiers in Pharmacology|September 4, 2023
How can patient preferences be used and communicated in the regulatory evaluation of medicinal products? Findings and recommendations from IMI PREFER and call to actionRosanne Janssens, Liese Barbier, Mireille Muller, et al.
Frontiers in Pharmacology|December 19, 2019
Design, Conduct, and Use of Patient Preference Studies in the Medical Product Life Cycle: A Multi-Method StudyEline van Overbeeke, Rosanne Janssens, Chiara Whichello, et al.
Frontiers in Pharmacology|October 18, 2019
Factors and Situations Affecting the Value of Patient Preference Studies: Semi-Structured Interviews in Europe and the USChiara Whichello, Eline van Overbeeke, Rosanne Janssens, et al.
The Patient|June 22, 2019
Patient Preferences in the Medical Product Life Cycle: What do Stakeholders Think? Semi-Structured Qualitative Interviews in Europe and the USARosanne Janssens, Selena Russo, Eline van Overbeeke, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Drug Discovery Today|September 30, 2018
Factors and situations influencing the value of patient preference studies along the medical product lifecycle: a literature reviewEline van Overbeeke, Chiara Whichello, Rosanne Janssens, et al.
Health Policy (Amsterdam, Netherlands)|August 26, 2020
An overview of critical decision-points in the medical product lifecycle: Where to include patient preference information in the decision-making process?Chiara Whichello, Karin Schölin Bywall, Jonathan Mauer, et al.
International Journal of Technology Assessment in Health Care|March 10, 2015
Developing the HTA core model for the online environmentKristian Lampe, Iris Pasternack, Oskari Saarekas, et al.
BMC Medical Informatics and Decision Making|October 6, 2019
Opportunities and challenges for the inclusion of patient preferences in the medical product life cycle: a systematic reviewRosanne Janssens, Isabelle Huys, Eline van Overbeeke, et al.
International Journal of Technology Assessment in Health Care|December 25, 2009
Testing the HTA core model: experiences from two pilot projectsIris Pasternack, Heidi Anttila, Marjukka Mäkelä, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|August 18, 2021
Belgian population norms for the EQ-5D-5L, 2018Lisa Van Wilder, Rana Charafeddine, Philippe Beutels, et al.
Frontiers in Pharmacology|September 4, 2023
How can patient preferences be used and communicated in the regulatory evaluation of medicinal products? Findings and recommendations from IMI PREFER and call to actionRosanne Janssens, Liese Barbier, Mireille Muller, et al.
Frontiers in Pharmacology|December 19, 2019
Design, Conduct, and Use of Patient Preference Studies in the Medical Product Life Cycle: A Multi-Method StudyEline van Overbeeke, Rosanne Janssens, Chiara Whichello, et al.
Frontiers in Pharmacology|October 18, 2019
Factors and Situations Affecting the Value of Patient Preference Studies: Semi-Structured Interviews in Europe and the USChiara Whichello, Eline van Overbeeke, Rosanne Janssens, et al.
The Patient|June 22, 2019
Patient Preferences in the Medical Product Life Cycle: What do Stakeholders Think? Semi-Structured Qualitative Interviews in Europe and the USARosanne Janssens, Selena Russo, Eline van Overbeeke, et al.
Pageof 8